Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study

Introduction Red cell distribution width (RDW) is associated with cardiovascular diseases, including atrial fibrillation (AF) and venous thromboembolism (VTE). Whether RDW is a risk marker for thromboembolic events in AF patients is scarcely known. We aimed to assess the association between RDW and...

Full description

Bibliographic Details
Main Authors:	Erin M. Hald, Maja-Lisa Løchen, Jostein Lappegård, Trygve S. Ellingsen, Ellisiv B. Mathiesen, Tom Wilsgaard, Inger Njølstad, Sigrid K. Brækkan, John-Bjarne Hansen
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2020-07-01
Series:	TH Open
Subjects:	venous thrombosis arterial thrombosis epidemiological studies red cell distribution width
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716417

Similar Items

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
by: Caroline Lind, et al.
Published: (2017-06-01)

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study
by: Jostein Lappegård, et al.
Published: (2018-04-01)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
by: Erin Mathiesen Hald, et al.
Published: (2020-08-01)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.
by: Birgit Småbrekke, et al.
Published: (2016-01-01)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
by: Joakim K. Sejrup, et al.
Published: (2020-02-01)

Role of microRNAs in Venous Thromboembolism
by: Vânia M. Morelli, et al.
Published: (2020-04-01)

Thromboembolic complications in nephrotic syndrome
by: Larisa A. Bobrova, et al.
Published: (2020-07-01)

Thromboembolic events in patients with inflammatory bowel disease
by: Farjah H Algahtani, et al.
Published: (2016-01-01)

Rheumatoid arthritis and venous thromboembolic events
by: M. A. Satybaldyeva
Published: (2016-10-01)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.
by: Lars Daae Horvei, et al.
Published: (2016-01-01)

Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study
by: Henning Nilius, et al.
Published: (2021-10-01)

Neonatal Venous Thromboembolism
by: Kristina M. Haley
Published: (2017-06-01)

Highly Elevated Quantitative D-Dimer Assay Values Increase the Likelihood of Venous Thromboembolism
by: Samuel Francis, et al.
Published: (2019-01-01)

Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012
by: Maria Carlsson, et al.
Published: (2016-08-01)

Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis
by: Erdem A, et al.
Published: (2016-09-01)

Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study
by: Goodarz Danaei, et al.
Published: (2020-05-01)

The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study.
by: Rolf Jorde, et al.
Published: (2015-01-01)

Prevention and treatment ofvenous thromboembolism. Case report
by: Andrzej Kolbuszewski, et al.
Published: (2015-06-01)

THE THROMBOEMBOLIC DISEASE IN CHILDREN (II) (TREATMENT AND MANAGEMENT)
by: Otilia-Elena Frasinariu, et al.
Published: (2017-06-01)

PERIOPERATIVE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ROUTINE ONCOSURGERY
by: V. E. Khoronenko, et al.
Published: (2016-12-01)

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
by: Stein Harald Johnsen, et al.
Published: (2018-05-01)

Thromboembolic prophylaxis in hernia surgery
by: Henry Hoffmann, et al.
Published: (2018-01-01)

HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
by: Michele Bibas, et al.
Published: (2011-01-01)

HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
by: Michele Bibas, et al.
Published: (2011-07-01)

THROMBOEMBOLIC DISEASE IN CHILDREN (EPIDEMIOLOGY, ETIOPATHOGENY AND DIAGNOSIS) (I)
by: Otilia-Elena Frasinariu, et al.
Published: (2016-06-01)

Mobile right atrial thrombus with pulmonary thromboembolism in a patient with advanced hepatocellular carcinoma and disseminated tumor thrombosis
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Significance of risk factors in the prevention of postpartum venous thromboembolic disease
by: S. V. Apresyan, et al.
Published: (2018-04-01)

Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial
by: Alok A. Khorana, et al.
Published: (2020-04-01)

Venous thromboembolism events among RA patients
by: Ribhi Mansour, et al.
Published: (2019-01-01)

Fatal cardiac thromboembolism in a patient with a pacemaker during ureteroscopic lithotripsy for ureter stone: a case report
by: Mee Young Chung, et al.
Published: (2015-02-01)

Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience
by: Yong-Su Jang, et al.
Published: (2021-07-01)

Venous thromboembolic disease in obstetrics
by: Rivas- Perdomo Édgar, et al.
Published: (2012-06-01)

Editorial: Pediatric Venous Thromboembolism
by: Brian R. Branchford, et al.
Published: (2018-09-01)

Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis
by: Mary Cushman, et al.
Published: (2020-07-01)

SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE
by: Nicola Semeraro, et al.
Published: (2010-08-01)

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!
by: Hikmat Abdel-Razeq, et al.
Published: (2018-03-01)

Efficacy and Safety of Pharmacological Thromboprophylactic Agents for the Prevention of Venous Thromboembolism after Major Abdominal Surgery
by: Al Rawahi, Bader
Published: (2017)

Pulmonary artery thromboembolism in a critically ill neonate successfully treated using thrombolytic therapy
by: Gerson Valencia Villeda, et al.
Published: (2021-01-01)

Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study.
by: Ieva Zostautiene, et al.
Published: (2015-01-01)

Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
by: Bosch A, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_5f87ii1tkbpritjd9r4tr2hbup